Rick Overkleeft, CEO 4MedBox, is a social impact entrepreneur in the bio-medical and health sector for the last 10 years. He has a bioinformatics background, but quickly became a leading bioinformatics enterprise architect and co-founded cooperatives and businesses around the concept of giving data ownership back towards the person. He gave lectures about data privacy in the medical sector and a TEDx talk about breaking the trend of data colonialism. He is also a guest researcher at the Leiden University Medical Center where he focusses on the FAIR principles, semantic web technology for the medical field, and synthetic DNA data.
He recently co-founded and became CEO of Primo Medda, a joint venture focussed on bringing Personalized Medicine as a service towards the places where it can make the most impact, while making sure that the person stays in control of their data.
- 11:15 am
- - 12:30 pm
Wednesday, December 4th, 2024
Despite the potential of digital health and innovative therapies to revolutionize healthcare, adoption and development remain complex challenges. What is the current state of the regulatory and reimbursement pathways for digital health and medicine? What to expect from the EHDS? What initiatives are underway to promote interoperability, data sharing and access to secondary use of health data? Have reimbursement processes like DiGA or PECAN proved their effectiveness in deploying digital health solutions? What are the key components of successful value proposition and revenue model for digital health innovations? How do investment strategies of VCs and big players influence the development and adoption of digital health technologies? How can further collaboration between healthcare providers, regulators, industry, and patients accelerate their adoption?
